Get App Open
In App
Credit Cards
Open App
you are here:
Success
Alert
Please select a Day.
Info

Wockhardt Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

42/100
1,478.80
2.90 (0.20%)

As on 05 Sep, 2025 | 03:57

Open Trading A/c
Day Range
1456.90
1490.00
L H
52 Week Range
915.00
1868.80
L H
Volume
199,686
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
50 1481.00 1482.00 19
79 1480.95 1482.75 5
16 1479.25 1482.95 5
80 1479.05 1483.00 5
5 1478.05 1483.20 5
0 Total Total 0
Bid / Ask
0.00 / 0.00
42/100
1,481.00
5.50 (0.37%)

As on 05 Sep, 2025 | 04:01

Open Trading A/c
Day Range
1458.55
1490.00
L H
52 Week Range
918.85
1870.00
L H
Volume
10,671
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
50 1481.00 1482.00 19
79 1480.95 1482.75 5
16 1479.25 1482.95 5
80 1479.05 1483.00 5
5 1478.05 1483.20 5
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
53% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 1,477.60
          Previous Close 1,475.90
          Volume 199,686.00
          Value (Lacs) 2,952.96
            VWAP 1,474.53
          Beta
          Mkt Cap (Rs. Cr.) 24,029
          High 1,490.00
          Low 1,456.90
          UC Limit 1,771.00
          LC Limit 1,180.80
          52 Week High 1,868.80
          52 Week Low 915.00
          Face Value 5.00
          All Time High 1,999.27
          All Time Low 61.30
          20D Avg Volume 442,915
          20D Avg Delivery(%) 37.08
          Book Value Per Share 209.19
          Dividend Yield 0.00
          TTM EPS See historical trend -7.57
          TTM PE See historical trend -- (Low PE)
          P/B See historical trend 7.07 (High P/B)
          Sector PE 39.40

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          42/100
          Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 20.87% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 49.09% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          12 out of 17 years Wockhardt has given positive returns in September.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          September 33.84% (2010) 10.99% -18.39% (2018) -6.60% 5.81%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Wockhardt

          What's your call on Wockhardt today?

          Read 8 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Wockhardt 1,478.80 0.20 24,029.34 - 7.07 -1.07 35.79 -57 3,012 0.43
          Sun Pharma 1,593.60 0.71 382,358.02 36.86 5.53 15.13 -12.75 10,980 52,578 0.03
          Divis Labs 6,009.00 -2.03 159,520.07 69.17 11.63 14.63 17.34 2,191 9,360 0.00
          Cipla 1,553.40 -1.55 125,476.52 23.27 4.42 16.90 -4.57 5,291 27,547 0.00
          Torrent Pharma 3,579.10 -0.56 121,133.01 60.51 16.14 25.17 3.97 1,911 11,516 0.40

          About the Company

          Wockhardt Ltd is engaged in the pharmaceutical and biotechnology segments.In the Biopharmaceutical segment the company has developed a basket of products such as Erythropoietin, Recombinant Human Insulin, Glargine are among others. The company sells 23 products under generic segment in US market.In new drug discovery area, they have developed a number of lead molecules in the anti-infective field.Currently the company has a significant presence in pain management, cough therapy, psychotic drugs, diabetology, vaccines, nutrition and animal health.The company has produced brands like Wosulin, Wepox, Proxyvon, Dexolac, Viscodyne, Libotryp, Methycobal and many more.
          {"success":1,"data":{"address":{"address1":"D-4, MIDC,","address2":",Chikalthana,","city":"Aurangabad","state":"Maharashtra","pincode":"431006","telephone1":"0240-6694444","telephone2":"","fax1":"0240-2489219","fax2":"","email":"investorrelations@wockhardt.com","web":"http:\/\/www.wockhardt.com"},"management":[{"name":"Habil Khorakiwala","designation":"Founder Chairman"},{"name":"Murtaza Khorakiwala","designation":"Managing Director"},{"name":"Huzaifa Khorakiwala","designation":"Executive Director"},{"name":"Zahabiya Khorakiwala","designation":"Non Executive Director"},{"name":"Tasneem Mehta","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"532300","nseId":"WOCKPHARMA","series":"EQ","isinid":"INE049B01025"}}}
          • Registered Office

          • Registrars

          • Management

            • Habil Khorakiwala

              Founder Chairman

            • Murtaza Khorakiwala

              Managing Director

            • Huzaifa Khorakiwala

              Executive Director

            • Zahabiya Khorakiwala

              Non Executive Director

            • Tasneem Mehta

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              532300

            • NSE:

              WOCKPHARMA

            • Series

              EQ

            • ISIN

              INE049B01025